Insider buying
~$88K40K sh @ $2.19
Traded Dec 23, 2024 · filed 3 days later
An Immix Biopharma director paid $88K out of pocket for Immix Biopharma shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 20, 2024 · Filed Dec 26, 2024
An Immix Biopharma director paid $17K out of pocket for Immix Biopharma shares. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$16,678
Shares × reported transaction price
<$25K
+0.9%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 14 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.9% | −0.5% | +5.4% |
| 30 days | −14.2% | +0.7% | −14.9% |
| 90 days | −23.7% | −4.7% | −19.0% |
| 180 days | −1.1% | +2.0% | −3.2% |
| 365 days | +146.0% | +15.6% | +130.4% |
Past results only. Not a forecast.
Insider buying
Traded Dec 23, 2024 · filed 3 days later
An Immix Biopharma director paid $88K out of pocket for Immix Biopharma shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.